Cargando…
A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer
Urachal adenocarcinomas (UrC) are rare but aggressive. Despite being of profound therapeutic relevance, UrC cannot be differentiated by histomorphology alone from other adenocarcinomas of differential diagnostic importance. As no reliable tissue-based diagnostic biomarkers are available, we aimed to...
Autores principales: | Neumann, Judith Martha, Niehaus, Karsten, Neumann, Nils, Knobloch, Hans Christoph, Bremmer, Felix, Krafft, Ulrich, Kellner, Udo, Nyirády, Peter, Szarvas, Tibor, Bednarz, Hanna, Reis, Henning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367814/ https://www.ncbi.nlm.nih.gov/pubmed/34021261 http://dx.doi.org/10.1038/s41374-021-00612-7 |
Ejemplares similares
-
Correction to: A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer
por: Neumann, Judith Martha, et al.
Publicado: (2021) -
Subtyping non-small cell lung cancer by histology-guided spatial metabolomics
por: Neumann, Judith Martha, et al.
Publicado: (2021) -
Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data
por: Reis, Henning, et al.
Publicado: (2018) -
Commentary: Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal Tumor
por: Szarvas, Tibor, et al.
Publicado: (2022) -
Prevalence of APC and PTEN Alterations in Urachal Cancer
por: Nagy, Nikolett, et al.
Publicado: (2020)